E. Claire Dees

2.4k total citations
52 papers, 1.8k citations indexed

About

E. Claire Dees is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, E. Claire Dees has authored 52 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in E. Claire Dees's work include Cancer Treatment and Pharmacology (15 papers), HER2/EGFR in Cancer Research (12 papers) and Pharmacogenetics and Drug Metabolism (8 papers). E. Claire Dees is often cited by papers focused on Cancer Treatment and Pharmacology (15 papers), HER2/EGFR in Cancer Research (12 papers) and Pharmacogenetics and Drug Metabolism (8 papers). E. Claire Dees collaborates with scholars based in United States, Belgium and Germany. E. Claire Dees's co-authors include Lisa A. Carey, Barbara K. Rimer, Roger B. Cohen, Noel T. Brewer, Suzanne C. O’Neill, Sarah E. Lillie, Jeffrey R. Infante, Shyeilla V. Dhuria, Scott B. Cameron and Anthony J. Olszanski and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

E. Claire Dees

51 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Claire Dees United States	19	1.1k	575	318	318	190	52	1.8k
Amyé Tevaarwerk United States	25	1.2k 1.2×	508 0.9×	441 1.4×	425 1.3×	134 0.7×	102	2.2k
Mark Powell United States	21	720 0.7×	454 0.8×	411 1.3×	122 0.4×	200 1.1×	52	1.7k
Alessandro Marco Minisini Italy	24	1.1k 1.1×	425 0.7×	603 1.9×	589 1.9×	147 0.8×	76	1.9k
Swati Biswas United States	21	645 0.6×	910 1.6×	149 0.5×	295 0.9×	144 0.8×	64	1.8k
Elena Ratner United States	30	1.0k 1.0×	654 1.1×	307 1.0×	294 0.9×	196 1.0×	145	2.4k
Katherine H. R. Tkaczuk United States	21	1.8k 1.7×	436 0.8×	387 1.2×	968 3.0×	166 0.9×	47	2.8k
Ramsey Cutress United Kingdom	27	773 0.7×	777 1.4×	187 0.6×	723 2.3×	82 0.4×	89	2.2k
Som D. Mukherjee Canada	25	968 0.9×	560 1.0×	499 1.6×	414 1.3×	136 0.7×	85	2.0k
Zhongfa Zhang China	24	342 0.3×	951 1.7×	426 1.3×	427 1.3×	99 0.5×	57	2.0k
Mark Verrill United Kingdom	23	1.3k 1.3×	409 0.7×	648 2.0×	473 1.5×	313 1.6×	85	2.4k

Countries citing papers authored by E. Claire Dees

Since Specialization

Citations

This map shows the geographic impact of E. Claire Dees's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Claire Dees with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Claire Dees more than expected).

Fields of papers citing papers by E. Claire Dees

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Claire Dees. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Claire Dees. The network helps show where E. Claire Dees may publish in the future.

Co-authorship network of co-authors of E. Claire Dees

This figure shows the co-authorship network connecting the top 25 collaborators of E. Claire Dees. A scholar is included among the top collaborators of E. Claire Dees based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Claire Dees. E. Claire Dees is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abdou, Yara, E. Claire Dees, Joanne Mortimer, et al.. (2023). Abstract CT241: A phase 1, first-in-human (FIH) study of autologous anti-HER2 chimeric antigen receptor macrophage (CAR-M) in participants (pt) with HER2 overexpressing solid tumors. Cancer Research. 83(8_Supplement). CT241–CT241. 2 indexed citations

Koch, Kevin M., E. Claire Dees, Nandi J. Reddy, et al.. (2017). The effects of lapatinib on CYP3A metabolism of midazolam in patients with advanced cancer. Cancer Chemotherapy and Pharmacology. 80(6). 1141–1146. 4 indexed citations

Buisseret, Laurence, Jennifer M. Specht, E. Claire Dees, et al.. (2015). KEYNOTE-012: A phase Ib study of pembrolizumab (MK-3475) in patients (pts) with metastatic triple-negative breast cancer (mTNBC). Annals of Oncology. 26. iii6–iii6. 6 indexed citations

Melichar, Bohuslav, Antoine Adenis, A. Craig Lockhart, et al.. (2015). Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study. The Lancet Oncology. 16(4). 395–405. 200 indexed citations

Lin, Nancy U., Hao Guo, Jeffrey T. Yap, et al.. (2015). Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [¹⁸F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003). Journal of Clinical Oncology. 33(24). 2623–2631. 42 indexed citations

Lu, Dan, Howard A. Burris, Bei Wang, et al.. (2012). Drug Interaction Potential of Trastuzumab Emtansine (T-DM1) Combined with Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer. Current Drug Metabolism. 13(7). 911–922. 30 indexed citations

Hertz, Daniel L., Christine M. Walko, Arlene S. Bridges, et al.. (2012). Pilot study of rosiglitazone as an in vivo probe of paclitaxel exposure. British Journal of Clinical Pharmacology. 74(1). 197–200. 7 indexed citations

Lin, NU, Ingrid A. Mayer, Julie Najita, et al.. (2011). TBCRC 003: Phase II trial of trastuzumab (T) and lapatinib (L) in patients (pts) with HER2+ metastatic breast cancer (MBC).. Journal of Clinical Oncology. 29(15_suppl). 527–527. 8 indexed citations

Muss, H. B., Jairam Krishnamurthy, Shani Alston, et al.. (2011). P16^INK4aexpression after chemotherapy in older women with early-stage breast cancer.. Journal of Clinical Oncology. 29(15_suppl). 9002–9002. 6 indexed citations

10.

Partridge, AH, Emily Blood, E. Claire Dees, et al.. (2008). Risk Perceptions and Psychosocial Outcomes of Women With Ductal Carcinoma In Situ: Longitudinal Results From a Cohort Study. JNCI Journal of the National Cancer Institute. 100(4). 243–251. 140 indexed citations

11.

Graf, Tyler N., Daniel R. Carrizosa, Angela D. M. Kashuba, et al.. (2008). Identification of a Cranberry Juice Product that Inhibits Enteric CYP3A-Mediated First-Pass Metabolism in Humans. Drug Metabolism and Disposition. 37(3). 514–522. 34 indexed citations

12.

Brewer, Noel T., Suzanne C. O’Neill, Sarah E. Lillie, et al.. (2008). The interaction of post‐traumatic growth and post‐traumatic stress symptoms in predicting depressive symptoms and quality of life. Psycho-Oncology. 17(9). 948–953. 187 indexed citations

13.

Isoherranen, Nina, Raymond C. Givens, Jatinder K. Lamba, et al.. (2007). The Influence of CYP3A5 Expression on the Extent of Hepatic CYP3A Inhibition Is Substrate-Dependent: An in Vitro-in Vivo Evaluation. Drug Metabolism and Disposition. 36(1). 146–154. 34 indexed citations

14.

Dees, E. Claire & Robert Z. Orlowski. (2006). Targeting the Ubiquitin–Proteasome Pathway In Breast Cancer Therapy. Future Oncology. 2(1). 121–135. 22 indexed citations

15.

Neuman, Heather B., Lisa A. Carey, David W. Ollila, et al.. (2006). Axillary lymph node count is lower after neoadjuvant chemotherapy. The American Journal of Surgery. 191(6). 827–829. 47 indexed citations

16.

Spector, Neil L., Wenle Xia, Howard A. Burris, et al.. (2005). Study of the Biologic Effects of Lapatinib, a Reversible Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, on Tumor Growth and Survival Pathways in Patients With Advanced Malignancies. Journal of Clinical Oncology. 23(11). 2502–2512. 290 indexed citations

17.

Dees, E. Claire, Sharyn D. Baker, Séamus O’Reilly, et al.. (2005). A Phase I and Pharmacokinetic Study of Short Infusions of UCN-01 in Patients with Refractory Solid Tumors. Clinical Cancer Research. 11(2). 664–671. 49 indexed citations

18.

Dees, E. Claire, et al.. (2004). Clinical summary of 67 heavily pre-treated patients with metastatic carcinomas treated with GW572016 in a phase Ib study. Journal of Clinical Oncology. 22(14_suppl). 3188–3188. 13 indexed citations

19.

Dees, E. Claire, H. Hurwitz, Afshin Dowlati, et al.. (2004). Clinical summary of 67 heavily pre-treated patients with metastatic carcinomas treated with GW572016 in a phase Ib study. Journal of Clinical Oncology. 22(14_suppl). 3188–3188. 4 indexed citations

20.

Feller, Axel‐Mario, et al.. (1996). Increase of Immunologically Relevant Parameters in Correlation with Baker Classification in Breast Implant Recipients. Annals of Plastic Surgery. 36(5). 512–521. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact